4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,155.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 1,820.00
  • 52 Week Low: 950.00
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 2,420
  • Market Cap: £178.98m
  • Beta: 0.02

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £12,909,296
Amy Walker 44,016 £508,385
Maria Del Pilar de la Huerta 6,667 £77,004
Hansjörg Plaggemars 6,667 £77,004
Timothy Paul McCarthy 2,388 £27,581

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,071,073 £58,570,893
DELPHI Unternehmensberatung AG 5,071,073 £58,570,893
M&G Plc 4,627,741 £53,450,409
Elevage Medical Technologies Holdings 4,627,741 £53,450,409
Deutsche Balaton AG 4,432,637 £51,196,957
4bb AG 3,665,242 £42,333,545
2invest AG 2,229,083 £25,745,909
Sparta AG 1,351,718 £15,612,343
Latonba AG 778,891 £8,996,191
Franciscus De Busschere 537,255 £6,205,295

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,155.00p
Change Today 35.00p
% Change 3.13 %
52 Week High 1,820.00
52 Week Low 950.00
Volume 2,420
Shares Issued 15.50m
Market Cap £178.98m
Beta 0.02

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.99% below the market average21.99% below the market average21.99% below the market average21.99% below the market average21.99% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
62.09% above the market average62.09% above the market average62.09% above the market average62.09% above the market average62.09% above the market average
70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average
Income Not Available
Growth
38.10% above the market average38.10% above the market average38.10% above the market average38.10% above the market average38.10% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

4basebio Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
15:28 1,500 @ 1,150.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page